Citation Impact
Citing Papers
Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.
2007
Combined corticosteroid and long-acting beta 2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
2013
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: PRISMS – Practical systematic RevIew of Self-Management Support for long-term conditions
2014 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD
2006
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
2009
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
Integrated care prevents hospitalisations for exacerbations in COPD patients
2006 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Monitoring in chronic disease: a rational approach
2005
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease
2004
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
COPD exacerbations {middle dot} 5: Management
2006
What have we learned from large drug treatment trials in COPD?
2007
Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD
2008
Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
2006
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
2006 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD
2008
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design
2005 Standout
Development and first validation of the COPD Assessment Test
2009 Standout
A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
2007
Interpretative strategies for lung function tests
2005 Standout
Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
2008
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
2007 Standout
COPD, a multicomponent disease: implications for management
2005
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Nocturnal cardiac arrhythmia in patients with obstructive sleep apnea
2007
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Pharmacologic Interventions in Chronic Obstructive Pulmonary Disease: Bronchodilators
2007
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
2011
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
2008 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD
2004
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
2004
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
2012
Evidence for intensification of the global water cycle: Review and synthesis
2005 Standout
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
2014
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Logistica de coleta e transporte de material biologico e organizacao do laboratorio central no ELSA-Brasil
2013 Standout
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
2017
Physical Activity and Public Health in Older Adults
2007 Standout
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
2007
Pathophysiology of Sleep Apnea
2010 Standout
Questionario do ELSA-Brasil: desafios na elaboracao de instrumento multidimensional
2013 Standout
Linkages between Regional Trends in Monthly Maximum Flows and Selected Climatic Variables
2004
Works of Patrick Darken being referenced
Detecting changes in trends in water quality using modified Kendall's tau
2000
The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD
2003
Cardiovascular Safety of Salmeterol in COPDa
2003
Cilomilast Reduces Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD
2003